Diabetes Management Market Share with Comprehensive Analysis and Scope to 2019

Diabetes, scientifically known as diabetes mellitus, is a clinical condition where a person has an elevated blood glucose level. It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition specifically results in polyuria, increase in thrust and hunger.

Get a sample report: https://www.alliedmarketresearch.com/request-toc-and-sample/352?utm_source=openpr&utm_medium=Niranjan

There is a high prevalence of type II diabetes worldwide due to increased obesity, urbanization, poor diet and substandard healthcare conditions. The global market for diabetes is highly lucrative for drug and device manufacturers as treatment majorly demands therapeutic and diagnostic management. Global diabetes management market is growing with high CAGR and expected to continue this trend for the forecast period.

The report addresses the key themes such as market segmentation and competitive landscape. This report is investigative towards trends, opportunities, and challenges present at the current marketplace for diabetes management and it also provides ample information therein. In-depth analysis of market dynamics coupled with upcoming trends would be beneficial to professionals. The report would contain detailed information about key leaders with their business share.

The prime driver for global diabetes management market is increasing the incidence of type I and type II diabetes combined with high obese population. Additionally, combination therapy as compared to monotherapy is gaining popularity due to its high efficacious nature. Increase in collaborations and alliances are better avenues to attain high profitability.

Purchase Report @Discount: https://www.alliedmarketresearch.com/checkout/785105?utm_source=openpr&utm_medium=Niranjan

However, the global diabetes management market suffers from some of the critical restrains namely, counterfeiting of drugs, scarcity of healthcare personnel in some countries such as Russia, cost sensitivity and limited infrastructure for management. Emerging economies offer ample opportunities to big players of this market to expand their business. Also, there is a need for improved, efficacious and safe treatment, which can be fulfilled by innovative R&D.

Global Diabetes Management Market by Device Type:

The diabetes management market is segmented by type of devices into monitoring, diagnostic, insulin delivery, and other devices. Blood glucose monitoring devices have the largest market share, as critical monitoring of glucose level is necessary for the management of diabetes. Also, the insulin delivery devices have increased its sale to promising value, which has resulted in improvement in insulin delivery technology. In this segment, insulin pens are more popular as they are less painful in usage.

Global Diabetes Management Market by Therapeutics:

The global diabetes management market is segmented by therapeutics into two broad categories, namely injectables and orally administered drugs. Therapeutic segment as a whole is largely dominated by human insulin and its analogues. Currently, dipeptidyl inhibitors have boosted the market growth and generated high revenue due to its safe nature and once daily dose regimen. Strong R&D pipeline has lead to the development of safe and efficacious drugs, which has further fueled market growth.

Global Diabetes Management Market by Geography:

Geographically, diabetes management market is segmented into North America, Europe, Asia, and LAMEA. North America and Asia-pacific dominate diabetes management market due to high incidences of diabetes and the large pool of the aging population. Currently, China is evolving as one of the major pharma markets for diabetes care and management. The reasons studied are robust economic growth, an aging population, and sweeping healthcare reforms.

Competitive Landscape:

The leading companies in the global diabetes management market include Abbott Laboratories, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi, Dexcom, Medtronic, and Novo Nordisk A/S. Currently, Abbott, Dexcom, and Medtronic dominate continuous glucose monitoring devices market and have launched several new products. Eli Lilly and Novo Nordisk have concentrated on the Indian market and have launched easy-to-use insulin versions to snatch high market share. Also, companies are focusing on collaborations and partnerships to gain profitability.

High-Level Analysis:

The study provides an in-depth analysis of market drivers, challenges and trends. Competitive landscape section provides explicit information of the big players ruling the global diabetes management market and their operating strategies. The report covers the qualitative analysis of market segments and identifies the prime areas for product targeting. Porter’s five forces tool has been utilized to determine the attractiveness within the global diabetes management market.

The constant demand for safe and efficacious therapeutics and improved technology is responsible to increase the bargaining power of the supplier. Innovative, differentiated and easy to use insulin delivery devices tend to decrease the threat of substitute products. Global diabetes management market has experienced across segment participation that resulted in shifting the business of big players to more diversified products. Thus, it tends to increase the threat of substitute products and keeps the high intensity of the rivalry.

KEY BENEFITS
• This report offers the following benefits in particular:
• Qualitative analysis of market trends, drivers and restraints within the global diabetes management market.
• Identification of leading companies within the global diabetes management market combined with ample information on competitive landscape and leading technologies would give a better understanding of the market players and their strategies.
• Insightful analysis of different segments helps to understand and capitalize future opportunities.
• Identification of emerging economies such as India and China, and opportunities therein.

KEY DELIVERABLES

The global diabetes management market is segmented into three major categories such as devices types, therapeutics, and geography.

MARKET BY DEVICE TYPE
Monitoring Devices
Blood Glucose Meters
Lancets
Blood Sampling Devices
Diagnostic Devices
Hemoglobin A1c
Hemoglobin A1c Kits
Hemoglobin A1c Meters
Insulin Delivery Devices
Insulin Pumps
Insulin Pens
Disposable Insulin Pens
Insulin Syringes
Reusable Insulin Pens
Other Devices
Artificial Pancreas
Commercial Software
Software Programs for Diabetes Monitoring
Web Software

MARKET BY THERAPEUTICS
Injectables
Insulin
Exenatide
Oral Drugs
Metformin
Sulfonylureas
Alpha glycosidase Inhibitors
Dipeptidyl Inhibitors
Meglitinides
Thaizolidinediones
Combination Medications

MARKET BY GEOGRAPHY
North America
Europe
Asia-Pacific
LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.